Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Celularity Inc (CELU)

Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies GlobeNewswire - Thu Jun 4, 7:00AM CDT

FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company pioneering placental-derived...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
Celularity Releases CEO Letter to Shareholders GlobeNewswire - Wed Jun 3, 3:15PM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
Celularity Appoints Rick Gonzalez as Chief Commercial Officer GlobeNewswire - Wed Jun 3, 7:00AM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a longevity-focused regenerative and cellular medicine company pioneering...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
Celularity Receives Nasdaq Notice Regarding Form 10-Q GlobeNewswire - Fri May 29, 4:15PM CDT

FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that it received...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation GlobeNewswire - Fri May 1, 3:30PM CDT

FLORHAM PARK, N.J., May 01, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a longevity-focused regenerative and cellular medicine company, today announced...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
NEXGEL Appoints Ian Blackman as Chief Financial Officer GlobeNewswire - Mon Apr 27, 8:00AM CDT

Veteran Financial and M&A Leader Appointed to Integrate Acquisition of Celularity, Scale the Business and Accelerate Growth LANGHORNE, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL”...

CELU : 0.6197 (+2.55%)
NXGL : 0.5646 (-0.25%)
NXGLW : 0.0386 (+59.50%)
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment GlobeNewswire - Tue Apr 21, 8:00AM CDT

Transaction expected to approximately triple NEXGEL’s annual revenue to approximately $35 million and is expected to be immediately accretive to profitability Licensing and acquiring a diversified...

CELU : 0.6197 (+2.55%)
NXGL : 0.5646 (-0.25%)
NXGLW : 0.0386 (+59.50%)
Celularity Announces Closing of Transaction with NexGel GlobeNewswire - Tue Apr 21, 7:30AM CDT

FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced the closing of...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing GlobeNewswire - Fri Apr 17, 3:35PM CDT

FLORHAM PARK, N.J., April 17, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that on April...

CELU : 0.6197 (+2.55%)
CELUW : 0.0039 (-13.33%)
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products GlobeNewswire - Thu Mar 12, 7:45AM CDT

Consideration for portfolio will consist of a $15 million upfront cash payment and potentially an additional $20 million in milestone payments based on net sales targets related to the portfolio  ...

CELU : 0.6197 (+2.55%)
NXGL : 0.5646 (-0.25%)
NXGLW : 0.0386 (+59.50%)

Barchart Exclusives

Nike Beat Wall Street Estimates by a Mile. Why Investors Are Still Not Convinced. Barchart - Thu Jul 2, 6:30PM CDT
Nike crushed Wall Street's expectations, but investors remain focused on a turnaround that is still far from complete. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.